Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Total Liabilities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Total Liabilities for 9 consecutive years, with $9.2 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 42.49% to $9.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.2 million through Dec 2025, down 42.49% year-over-year, with the annual reading at $9.2 million for FY2025, 42.49% down from the prior year.
  • Total Liabilities for Q4 2025 was $9.2 million at Catheter Precision, down from $19.0 million in the prior quarter.
  • The five-year high for Total Liabilities was $19.0 million in Q3 2025, with the low at -$9.8 million in Q2 2022.
  • Average Total Liabilities over 5 years is $10.0 million, with a median of $9.8 million recorded in 2021.
  • The sharpest move saw Total Liabilities tumbled 224.0% in 2022, then soared 220.02% in 2023.
  • Over 5 years, Total Liabilities stood at $7.4 million in 2021, then rose by 2.78% to $7.6 million in 2022, then rose by 25.96% to $9.5 million in 2023, then soared by 67.8% to $16.0 million in 2024, then plummeted by 42.49% to $9.2 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $9.2 million, $19.0 million, and $19.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.